Posted in | News

LANXESS to Offer Colored Concrete Solutions to South Korean Construction Market

LANXESS’ Inorganic Pigment business unit, one among the major producers of iron oxide pigments, along with Wooshin Pigment, a South Korean company, has demonstrated the superior properties of colored concrete obtained by utilizing LANXESS’ Bayferrox pigments at the 4th Colored Concrete Works Forum.

4th Colored Concrete Works Forum

LANXESS, a major specialty chemicals company, has conducted the forum in June 23, 2011 at Grand Hyatt located in Seoul, South Korea. The company has also presented the benefits of chrome oxide and iron oxide pigments.

Bayferrox pigments offer a natural warm color to the concrete material, making it a growing trend in the modernized concrete architecture in South Korea. LANXESS’ Bayferrox inorganic iron oxide pigments complement the trend by offering superior tinting strength, color consistency and weather resistance.

According to Dr. Wolfgang Oehlert, who serves as VP of the Inorganic Pigment business unit for Asia Pacific at LANXESS, the choice of Seoul as the first Asian location for the Colored Concrete Works Forum explains the significance of the Asian markets, particularly the South Korean market. The company will offer colored concrete’s sustainable technical expertise and tailored solutions to South Korea’s rapidly modernizing and expanding architectural culture.

At the forum, LANXESS’ Head of the Global Competence Center Construction, Lutz Kohnert explained the technical uses of Bayferrox pigment and its ability to serve as an efficient solution for coloring the concrete. He demonstrated the aesthetic appeal of colored concrete with examples across the world, including Emirates Palace Hotel in Abu Dhabi, New Astra Bridge in Stockholm in Sweden and Soccer City Stadium in Johannesburg, South Africa.

Source: http://lanxess.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). LANXESS to Offer Colored Concrete Solutions to South Korean Construction Market. AZoBuild. Retrieved on April 25, 2024 from https://www.azobuild.com/news.aspx?newsID=14121.

  • MLA

    Scanlon, Joel. "LANXESS to Offer Colored Concrete Solutions to South Korean Construction Market". AZoBuild. 25 April 2024. <https://www.azobuild.com/news.aspx?newsID=14121>.

  • Chicago

    Scanlon, Joel. "LANXESS to Offer Colored Concrete Solutions to South Korean Construction Market". AZoBuild. https://www.azobuild.com/news.aspx?newsID=14121. (accessed April 25, 2024).

  • Harvard

    Scanlon, Joel. 2019. LANXESS to Offer Colored Concrete Solutions to South Korean Construction Market. AZoBuild, viewed 25 April 2024, https://www.azobuild.com/news.aspx?newsID=14121.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.